Patents by Inventor Lianping XING

Lianping XING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bortezomib conjugates and methods using same
    Patent number: 11497813
    Abstract: The present invention provides compositions and methods for providing controllable local delivery of a conjugate of bortezomib (Btz) and a bisphosphonate to promote bone formation. In certain embodiments, the invention is used as a treatment for a subject with diseases and disorders characterized by bone loss.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: November 15, 2022
    Assignee: BIOVINC, LLC
    Inventors: Frank Ebetino, Robert Boeckman, Lianping Xing, Lifeng Xiao, Brendan Boyce
  • Bortezomib Conjugates and Methods Using Same
    Publication number: 20180318425
    Abstract: The present invention provides compositions and methods for providing controllable local delivery of a conjugate of bortezomib (Btz) and a bisphosphonate to promote bone formation. In certain embodiments, the invention is used as a treatment for a subject with diseases and disorders characterized by bone loss.
    Type: Application
    Filed: November 2, 2016
    Publication date: November 8, 2018
    Inventors: Frank Ebetino, Robert Boeckman, Lianping Xing, Lifeng Xiao, Brendan Boyce
  • METHOD TO IDENTIFY PATIENTS THAT WILL LIKELY RESPOND TO ANTI-TNF THERAPY
    Publication number: 20150369823
    Abstract: The present invention identifies various methods for the identification of patients that suffer from an immune system disorder and are likely to benefit from anti-TNF therapy. Because of the significant cost of anti-TNF therapy and the high rate of ineffectiveness of anti-TNF therapy for treating immune disorders such as rheumatoid and psoriatic arthritis, the present invention will improve the delivery of effective therapies to patients in need of either anti-TNF therapy or alternative therapies.
    Type: Application
    Filed: January 10, 2014
    Publication date: December 24, 2015
    Applicant: UNIVERSITY OF ROCHESTER
    Inventors: Brendan F. BOYCE, Lianping XING, Christopher T RITCHLIN, Yan XIU
  • METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS
    Publication number: 20140056919
    Abstract: The present invention is directed to methods of treating an inflammatory condition in a patient. This method includes providing a therapeutic agent that is a vascular endothelial growth factor receptor-3 (VEGFR-3) agonist or a nucleic acid molecule encoding a VEGFR-3 agonist. The present invention is further directed to pharmaceutical compositions and therapeutic systems for treating an inflammatory condition.
    Type: Application
    Filed: October 31, 2013
    Publication date: February 27, 2014
    Applicant: UNIVERSITY OF ROCHESTER
    Inventors: Lianping XING, Brendan F. BOYCE, Edward M. SCHWARZ
  • Methods and compositions for treating inflammatory conditions
    Patent number: 8580755
    Abstract: The present invention is directed to methods of treating an inflammatory condition in a patient. This method includes providing a therapeutic agent that is a vascular endothelial growth factor receptor-3 (VEGFR-3) agonist or a nucleic acid molecule encoding a VEGFR-3 agonist. The present invention is further directed to pharmaceutical compositions and therapeutic systems for treating an inflammatory condition.
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: November 12, 2013
    Assignee: University of Rochester
    Inventors: Lianping Xing, Brendan F. Boyce, Edward M. Schwarz
  • METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS
    Publication number: 20090232829
    Abstract: The present invention is directed to methods of treating an inflammatory condition in a patient. This method includes providing a therapeutic agent that is a vascular endothelial growth factor receptor-3 (VEGFR-3) agonist or a nucleic acid molecule encoding a VEGFR-3 agonist. The present invention is further directed to pharmaceutical compositions and therapeutic systems for treating an inflammatory condition.
    Type: Application
    Filed: February 19, 2009
    Publication date: September 17, 2009
    Applicant: UNIVERSITY OF ROCHESTER
    Inventors: Lianping XING, Brendan F. BOYCE, Edward M. SCHWARZ